• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD R3 44MM ID INTL COCR LINER 56MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD R3 44MM ID INTL COCR LINER 56MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 71335856
Device Problem Biocompatibility (2886)
Patient Problems Inflammation (1932); Osteolysis (2377); Fibrosis (3167); Metal Related Pathology (4530)
Event Date 03/27/2018
Event Type  Injury  
Manufacturer Narrative
Internal complaint reference (b)(4).
 
Event Description
(b)(6) it was reported that after a r3 tha construct was implanted on (b)(6) 2010 the plaintiff experienced an aseptic lymphocyte-dominant vasculitis-associated lesion reaction (alval), elevated ion levels on blood, and pseudotumor on left hip.A revision surgery was performed on (b)(6) 2018 to treat these adverse events.During the revision surgery a brownish solid mass whose was solid, pasty, and brownish was found.Also, a peripheral osteolysis at the acetabular level and at the medial level on the calcar for the femur was noted.After the surgery, microscopic study of the solid mass revealed reactive fibrosis with amorphous substance, chronic inflammation and fibro histiocytic reaction associated with a black pigment and siderophages.The patient outcome is unknown.
 
Manufacturer Narrative
H3, h6: it was reported that left hip revision surgery was performed.During the revision the r3 liner and modular head were explanted.As of today, the implanted devices, all of which were used in treatment, and additional information have been requested for this complaint but have not become available.A review of the complaint history for the r3 liner, modular head, modular sleeve, r3 shell and stem was performed using batch numbers in search of similar recurring reports for the products during their lifetimes.No other similar complaints were identified for the r3 liner, modular head, r3 shell, or stem.Similar complaints have been identified for the sleeve, however, as the device is no longer sold, no action is to be taken.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All the released devices involved met manufacturing specifications upon release for distribution.Review of manufacturing records did not reveal any waivers, concessions, manufacturing, or material abnormalities that could have contributed to this issue.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.No additional risks were identified as result of the reported event.No further actions are required at this time.The available medical documents were reviewed.Although it was reported the patient experienced an aseptic lymphocyte-dominant vasculitis-associated lesion reaction, the pathology report did not confirm.The reported elevated metal ions and intraoperative findings of pseudotumor, brown pasty tissue and osteolysis along with the pathological findings may be consistent with an adverse reaction to metal debris.However, the clinical root cause cannot be confirmed.It cannot be concluded that the reported clinical reactions were associated with a malperformance of the implant or implant failure.The patient impact beyond the revision and expected transient post-operative convalescence period cannot be determined.Without the return of the actual products involved or additional information, our investigation remains inconclusive, and a definitive root cause cannot be determined.Based on the limited information provided we are unable to speculate on specific factors known to contribute to the alleged fault.Should the device or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
R3 44MM ID INTL COCR LINER 56MM
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key12526314
MDR Text Key273125768
Report Number3005975929-2021-00430
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010596123
UDI-Public3596010596123
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/24/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/29/2018
Device Catalogue Number71335856
Device Lot Number08KW19581
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/25/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/31/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age70 YR
Patient SexMale
-
-